Ember Technologies and Cardinal Health Partner to Transform the Pharmaceutical Cold Chain
Ember Technologies and Cardinal Health (CAH) have announced a groundbreaking partnership to introduce the Ember Cube, the world's first self-refrigerated, cloud-based shipping box designed for temperature-sensitive medicines. This innovative shipping solution addresses the growing need for secure, sustainable cold chain logistics, as global spending is projected to exceed $21 billion by 2024. The Ember Cube features advanced tracking capabilities, real-time temperature monitoring, and reusable technology, significantly reducing waste from traditional packaging methods. A customer pilot is set for 2022.
- Introduction of the Ember Cube, a revolutionary shipping solution for temperature-sensitive medicines.
- Partnership aligns with the growing $21 billion cold-chain pharmaceutical market by 2024, enhancing market reach.
- Ember Cube features real-time monitoring of temperature and location, improving product integrity.
- Reusable technology reduces waste, contributing to sustainable practices in pharmaceutical logistics.
- None.
LOS ANGELES, Jan. 31, 2022 /PRNewswire/ -- Ember Technologies, Inc. (Ember®) and Cardinal Health (NYSE: CAH) today announced a partnership to offer the world's first self-refrigerated, cloud-based shipping box–the Ember Cube. Ember and Cardinal Health will collaborate to deliver a cold chain solution that ensures product integrity and security throughout the supply chain, while significantly reducing shipping waste in the transport of temperature-sensitive medicines.
The Ember Cube is a digital shipping box that features cloud-based temperature reporting, GPS location tracking, and return-to-sender technology, versus the current industry standard for transporting temperature-sensitive medicine which includes single-use ice packs, Styrofoam, and cardboard. The Ember Cube uses an onboard cellular radio to report real-time temperature and humidity tracking and GPS location information that can be viewed via Ember's proprietary cloud-based dashboard. This patented technology allows for precision control, so medicines and vaccines arrive at the required temperature range, ready for use.
"Since Ember's inception, it has been our goal to leverage our temperature control technology to serve the healthcare industry, with the ultimate mission of helping to improve and save lives," said Clay Alexander, Founder and Group CEO of Ember. "We have formed a powerful new partnership with Cardinal Health to codevelop and commercialize many of our patented healthcare industry inventions to bring this vision to life."
Cardinal Health plays a leading and critical role in delivering logistics solutions for specialty pharmaceutical products, which often have unique temperature requirements. As global spending on cold-chain pharmaceutical products grows to more than
"Cardinal Health is investing in digital solutions and technology to help our healthcare customers solve problems in innovative ways," said Heidi Hunter, President of Cardinal Health Specialty Solutions. "Our partnership with Ember utilizes technology solutions to set a new industry standard for real-time visibility and product integrity, while also providing transformative waste reduction."
"The Ember Cube will be a particularly relevant solution for the many cell and gene therapies that are in the drug development pipeline, due to their temperature sensitivity, high value and need for real-time integrated tracking," added Hunter.
Ember's return-to-sender technology allows each Ember Cube to be reused hundreds of times, reducing waste, and eliminating single-use packaging. Once a healthcare provider has received its shipment of medicine, the Ember Cube uses its built-in cellular radio to communicate with the shipping service to schedule a pick-up, automatically providing its current GPS location. Once the Ember Cube notifies the shipping service that it is ready to be picked up, it generates a new shipping label on its e-ink screen and is returned to Cardinal Health's distribution center.
Cardinal Health plans to launch a customer pilot for the Ember Cube in 2022.
About Ember Technologies, Inc.
Ember is a global temperature control brand and technology platform whose mission is to revolutionize the way people eat, drink and live. Founded by inventor and serial entrepreneur Clay Alexander, Ember creates, designs, and develops temperature control products that offer people complete customization. The award-winning Ember Travel Mug and Ember Mug are the most advanced coffee mugs on the market, allowing individuals to set and maintain their preferred drinking temperature for hot beverages. For more information, visit ember.com and connect with us on Facebook.com/ember, Instagram.com/ember, and Twitter.com/ember_tech.
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.
- Biopharma Cold Chain Sourcebook 2020
Media Contact:
Kristi Collura
kristi.collura@ember.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ember-technologies-and-cardinal-health-partner-to-transform-the-pharmaceutical-cold-chain-301471001.html
SOURCE Ember
FAQ
What is the Ember Cube launched by Cardinal Health and Ember Technologies?
When will the customer pilot for the Ember Cube begin?
How does the Ember Cube improve pharmaceutical shipping?
What market need does the partnership between Ember and Cardinal Health address?
What is the projected growth of the cold-chain pharmaceutical market?
